FDA Inspection 1203818 — Lucile Salter Packard Children's Hospital Stanford Medicine Fertility And Reproductive Health

Lucile Salter Packard Children's Hospital Stanford Medicine Fertility And Reproductive Health — FEI 3003971418

The FDA completed an inspection of Lucile Salter Packard Children's Hospital Stanford Medicine Fertility And Reproductive Health on Apr 27, 2023 in Sunnyvale, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 27, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Sunnyvale, CA (United States)

Citations

IDCFRDescription
1228821 CFR 1271.80(c)Manufacturer instructions not followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.